Repeat hepatectomy versus microwave ablation for solitary and small (≤3 cm) recurrent hepatocellular carcinoma with early or late recurrence: A propensity score matched study

医学 肝细胞癌 倾向得分匹配 微波消融 肝切除术 内科学 外科 肿瘤科 放射科 切除术 烧蚀
作者
Wenqiang Wang,Xing Lv,Jian Li,Jiang Li,Jinlin Wang,Tong Yuan,Junjie Liu,Rong-Hua Zhu,Zhiyong Huang,Erlei Zhang
出处
期刊:Ejso [Elsevier]
卷期号:49 (5): 1001-1008 被引量:13
标识
DOI:10.1016/j.ejso.2022.12.016
摘要

Repeat hepatectomy (RH) and microwave ablation (MWA) are frequently used procedures for the treatment of recurrent hepatocellular carcinoma (HCC) after curative resection. This study aimed to compare the long-term outcomes of RH and MWA for solitary and small HCC with early or late recurrence.This retrospective study enrolled patients who underwent RH or MWA for solitary and small (≤3 cm) recurrent HCC at Tongji hospital between April 2006 and December 2020. Propensity score matching (PSM) was further employed to analyze the prognosis of different treatment methods.A total of 256 patients were analyzed, of whom 94 and 162 underwent RH and MWA, respectively. The overall treatment-related complication rate was higher in the RH group. Both recurrence-free survival (RFS) and overall survival (OS) rates of RH were significantly better than those of MWA. Multivariate analysis showed that MWA, early recurrence (within 24 months after initial resection), cirrhosis, and AFP >400 ng/ml were independent risk factors for poor prognoses of recurrent HCC. The stratified analysis demonstrated that MWA and RH had similar long-term outcomes in patients with early recurrence. Nevertheless, MWA had worse RFS and OS than RH in patients with late recurrence. The same results were obtained in the PSM analysis.The long-term outcomes of HCC patients with late recurrence were significantly better than those with early recurrence. RH should be the first choice for solitary small recurrent HCC patients with late recurrence, while MWA should be selected for those with early recurrence.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
wanci应助科研通管家采纳,获得10
刚刚
脑洞疼应助科研通管家采纳,获得10
刚刚
汉堡包应助科研通管家采纳,获得10
刚刚
英俊的铭应助科研通管家采纳,获得10
刚刚
大个应助科研通管家采纳,获得10
刚刚
Akim应助科研通管家采纳,获得10
刚刚
小二郎应助科研通管家采纳,获得10
刚刚
20011013发布了新的文献求助10
刚刚
无极微光应助科研通管家采纳,获得30
刚刚
Jasper应助科研通管家采纳,获得10
1秒前
1秒前
orixero应助科研通管家采纳,获得10
1秒前
小蘑菇应助科研通管家采纳,获得10
1秒前
隐形曼青应助科研通管家采纳,获得30
1秒前
所所应助科研通管家采纳,获得10
1秒前
1秒前
Mic应助科研通管家采纳,获得30
1秒前
赘婿应助科研通管家采纳,获得10
1秒前
英俊的铭应助科研通管家采纳,获得10
1秒前
彭于晏应助科研通管家采纳,获得10
1秒前
丘比特应助科研通管家采纳,获得10
2秒前
F_echo应助科研通管家采纳,获得20
2秒前
领导范儿应助科研通管家采纳,获得10
2秒前
慕青应助科研通管家采纳,获得10
2秒前
2秒前
2秒前
自觉笑旋发布了新的文献求助10
2秒前
威武紫青发布了新的文献求助10
3秒前
樱桃园发布了新的文献求助10
4秒前
嘻嘻发布了新的文献求助10
5秒前
善学以致用应助雷大大采纳,获得10
5秒前
6秒前
liuliuliu完成签到,获得积分10
7秒前
爱开心完成签到 ,获得积分10
8秒前
9秒前
Party完成签到,获得积分10
9秒前
zm完成签到,获得积分20
9秒前
滴答滴答滴完成签到,获得积分10
9秒前
善学以致用应助又甘又刻采纳,获得10
10秒前
SciGPT应助又甘又刻采纳,获得30
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Modern Epidemiology, Fourth Edition 5000
Handbook of pharmaceutical excipients, Ninth edition 5000
Kinesiophobia : a new view of chronic pain behavior 5000
Molecular Biology of Cancer: Mechanisms, Targets, and Therapeutics 3000
Digital Twins of Advanced Materials Processing 2000
Weaponeering, Fourth Edition – Two Volume SET 2000
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 纳米技术 化学工程 生物化学 物理 计算机科学 内科学 复合材料 催化作用 物理化学 光电子学 电极 冶金 细胞生物学 基因
热门帖子
关注 科研通微信公众号,转发送积分 6019078
求助须知:如何正确求助?哪些是违规求助? 7611249
关于积分的说明 16160998
捐赠科研通 5166790
什么是DOI,文献DOI怎么找? 2765444
邀请新用户注册赠送积分活动 1747168
关于科研通互助平台的介绍 1635478